1. Home
  2. PAYO vs PTGX Comparison

PAYO vs PTGX Comparison

Compare PAYO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$7.14

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$138.70

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYO
PTGX
Founded
2005
2006
Country
United States
United States
Employees
N/A
141
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
9.3B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
PAYO
PTGX
Price
$7.14
$138.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$7.69
$108.23
AVG Volume (30 Days)
2.3M
498.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
2.35
Revenue
$1,052,774,000.00
N/A
Revenue This Year
$7.15
$874.25
Revenue Next Year
$10.28
N/A
P/E Ratio
$142.60
$61.73
Revenue Growth
7.68
N/A
52 Week Low
$4.08
$62.24
52 Week High
$7.18
$160.81

Technical Indicators

Market Signals
Indicator
PAYO
PTGX
Relative Strength Index (RSI) 54.05 49.01
Support Level $7.08 $141.95
Resistance Level $7.16 $151.24
Average True Range (ATR) 0.03 4.49
MACD -0.00 -0.52
Stochastic Oscillator 44.44 42.25

Price Performance

Historical Comparison
PAYO
PTGX

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: